No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Vimseltinib Produces Objective Radiological Responses in Tenosynovial Giant Cell Tumour Patients

byAngel GaoandAlisha Yi

July 1, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in Lancet.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

2 Minute Medicine Rewind July 1, 2024

RelatedReports

AI Roundup

2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]

July 2, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

July 2, 2025

Chronic Disease

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

July 2, 2025

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025

Combined immunotherapy may improve survival in metastatic pancreatic cancer

Subcutaneous amivantamab with lazertinib is non-inferior to intravenous administration, with fewer adverse reactions

Patient Basics: Large Cell Cancer of the Lung

Amivantamab and Lazertinib in Untreated EGFR-Mutated Advanced NSCLC

#VisualAbstract: Ridinilazole reduces recurrent Clostridioides difficile infection and preserves gut microbi-ome diversity versus vancomycin

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result